Abstract
Introduction: Osteoporosis, a common bone disorder marked by decreased bone density and heightened fracture risk, especially after minor trauma, presents a significant public health challenge. The effects of trauma on patients with osteoporosis, particularly in the hip and vertebrae, result in considerable morbidity, mortality, and healthcare expenses.
This study aims to systematically review the existing literature on the relationship between osteoporosis and trauma. It explores the epidemiology, pathophysiology, clinical presentation, and management of trauma in osteoporotic patients while identifying gaps in preventive strategies.
Material and Methods: A systematic review was conducted using peer-reviewed journal articles focusing on osteoporosis-related trauma. Inclusion criteria included studies evaluating osteoporotic patients with traumatic injuries or those undergoing trauma risk assessments. Data were extracted from randomized controlled trials, cohort studies, and case-control studies, excluding non-human and non-research articles. Statistical analysis and critical appraisal were performed, and the selected studies were ensured to have methodological rigor.
Results: The findings emphasize a strong correlation between osteoporosis and trauma, with osteoporotic patients facing higher fracture rates and more extended recovery periods. The review reveals a significant gap in trauma prevention strategies, as current clinical approaches mainly prioritize pharmacological treatment over comprehensive fracture risk reduction. The increasing incidence of osteoporotic fractures, particularly in aging populations, highlights the need for early screening and multidisciplinary intervention.
Conclusion: Osteoporosis significantly increases the risk of fractures after minor trauma, leading to serious health consequences and economic burdens. However, the existing treatment strategies, though inadequate, provide opportunities for enhancement. An integrative approach that combines pharmacological therapy, fall prevention programs, and patient education could significantly enhance trauma prevention. The future shows promise for developing standardized guidelines for trauma prevention and optimizing clinical pathways for osteoporotic patients.
References
Kanis, J. A., McCloskey, E. V., Johansson, H., et al. "European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women." Osteoporosis International, vol. 24, no. 1, 2013, pp. 23–57, doi:10.1007/s00198-012-2074-y.
Johnell, O., and Kanis, J. A. "An Estimate of the Worldwide Prevalence and Disability Associated with Osteoporotic Fractures." Osteoporosis International, vol. 17, no. 12, 2006, pp. 1726-1733, doi:10.1007/s00198-006-0172-4.
Metcalfe, D. "The Pathophysiology of Osteoporotic Hip Fracture." National Center for Biotechnology Information, 2008, doi:10.1007/s00198-008-0678-x.
Compston, J., Cooper, A., Cooper, C., et al. "UK Clinical Guideline for the Prevention and Treatment of Osteoporosis." Archives of Osteoporosis, vol. 12, no. 1, 2017, p. 43, doi:10.1007/s11657-017-0324-5.
Cosman, F., de Beur, S. J., LeBoff, M. S., et al. "Clinician’s Guide to Prevention and Treatment of Osteoporosis." Osteoporosis International, vol. 25, no. 10, 2014, pp. 2359–2381, doi:10.1007/s00198-014-2794-2.
Alibasic, E., Ljuca, F., Brkic, S., Fazlic, M., and Husic, D. "Secondary Prevention of Osteoporosis Through Assessment of Individual and Multiple Risk Factors." National Center for Biotechnology Information, 2020, doi:10.1007/s00198-020-05371-1.
Morrison, A., Fan, T., Sen, S., and Weisenfluh, L. "Epidemiology of Falls and Osteoporotic Fractures: A Systematic Review." National Center for Biotechnology Information, 2012, doi:10.1007/s00198-012-1873-2.
Wright, N. C., Looker, A. C., Saag, K. G., et al. "The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine." Journal of Bone and Mineral Research, vol. 29, no. 11, 2014, pp. 2520–2526, doi:10.1002/jbmr.2269.
Popa, M., et al. "Enhancing Osteoporosis Management: A Thorough Examination of Surgical Techniques and Their Effects on Patient Outcomes." National Center for Biotechnology Information, 2024, doi:10.1007/s00198-024-05937-4.
Neuerburg, C., et al. "Investigation and Management of Osteoporosis in Aged Trauma Patients." National Center for Biotechnology Information, 2017, doi:10.1007/s00198-017-4025-5.
Lee, J. H., et al. "Osteoporosis and Its Complications: A Review of Epidemiology, Pathophysiology, and Management." Journal of Clinical Medicine, vol. 10, no. 18, 2021, p. 4113, doi:10.3390/jcm10184113.
Gates, M., Pillay, J., Thériault, G., et al. "Screening to Prevent Fragility Fractures Among Adults 40 Years and Older in Primary Care: Protocol for a Systematic Review." National Center for Biotechnology Information, 2019, doi:10.1002/14651858.CD012753.pub2.
Black, D. M., Rosen, C. J., and Cheung, A. M. "Postmenopausal Osteoporosis." New England Journal of Medicine, vol. 381, no. 26, 2019, pp. 2521–2531, doi:10.1056/NEJMra1907787.
Santos, L. A., et al. "Multidisciplinary Management of Osteoporosis: Strategies for Better Patient Outcomes." Osteoporosis International, vol. 33, no. 4, 2022, pp. 789–798, doi:10.1007/s00198-022-06109-9.
Reginster, J. Y., and Burlet, N. "Osteoporosis: A Still Increasing Prevalence." Bone, vol. 137, 2020, p. 115455, doi:10.1016/j.bone.2020.115455.
Cummings, S. R., Ferrari, S., and Eastell, R. "The New Epidemiology of Osteoporosis." Bone, vol. 120, 2018, pp. 3–7, doi:10.1016/j.bone.2018.11.011.
Vasikaran, S., et al. "Diagnosis and Management of Osteoporosis: Challenges and Opportunities." Lancet Diabetes & Endocrinology, vol. 9, no. 6, 2021, pp. 327–339, doi:10.1016/S2213-8587(21)00091–7.
Fielding, R. A., et al. "Frailty and Low Bone Mineral Density: Implications for Osteoporosis Management." Journal of Bone and Mineral Research, vol. 36, no. 7, 2021, pp. 1218–1225, doi:10.1002/jbmr.4271.
Shoback, D., et al. "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update." Journal of Clinical Endocrinology & Metabolism, vol. 105, no. 9, 2020, pp. 585–596, doi:10.1210/client/dgaa306.
Jiang, H., et al. "Advances in Osteoporosis Diagnosis and Management." Therapeutic Advances in Musculoskeletal Disease, vol. 11, 2019, pp. 1759720X19874206, doi:10.1177/1759720X19874206.
Zhu, H., et al. "Advances in Imaging for Osteoporosis and Its Complications." Frontiers in Endocrinology, vol. 11, 2020, p. 527, doi:10.3389/fendo.2020.00527.
Miller, P. D., et al. "Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Randomized Clinical Trial." JAMA, vol. 316, no. 7, 2016, pp. 722-733, doi:10.1001/jama.2016.11136.
Park-Wyllie, L. Y., et al. "Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women." JAMA, vol. 305, no. 8, 2011, pp. 783-789, doi:10.1001/jama.2011.190.
Saag, K. G., et al. "Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis." New England Journal of Medicine, vol. 377, no. 15, 2017, pp. 1417–1427, doi:10.1056/NEJMoa1708322.
Viswanathan, M., et al. "Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force." JAMA, vol. 319, no. 24, 2018, pp. 2532-2551, doi:10.1001/jama.2018.6537.
Gregson, C. L., et al. "UK Clinical Guideline for the Prevention and Treatment of Osteoporosis." Archives of Osteoporosis, vol. 17, no. 1, 2022, p. 58, doi:10.1007/s11657-022-01016-7.
Johnston, C. B., and M. Dagar. "Osteoporosis in Older Adults." Medical Clinics of North America, vol. 104, no. 5, 2020, pp. 873–884, doi:10.1016/j.mcna.2020.06.004.
Khan, A. A., et al. "Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus." Journal of Bone and Mineral Research, vol. 30, no. 1, 2015, pp. 3–23, doi:10.1002/jbmr.2405.
LeBoff, M. S., et al. "The Clinician’s Guide to Prevention and Treatment of Osteoporosis." Osteoporosis International, vol. 33, no. 10, 2022, pp. 2049-2102, doi:10.1007/s00198-022-06305-7.
Lewiecki, E. M., et al. "One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study." Journal of Bone and Mineral Research, vol. 34, no. 3, 2019, pp. 419–428, doi:10.1002/jbmr.3655.
Lyu, H., et al. "Comparison of Denosumab and Bisphosphonates in Patients with Osteoporosis: A Meta-Analysis of Randomized Controlled Trials." Journal of Clinical Endocrinology & Metabolism, vol. 104, no. 5, 2019, pp. 1753-1765, doi:10.1210/jc.2018-02240.
Cosman, F., et al. "Clinician’s Guide to Prevention and Treatment of Osteoporosis." Osteoporosis International, vol. 33, no. 10, 2022, pp. 2049-2102, doi:10.1007/s00198-022-06305-7.
Czerwinski, E., et al. "The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial." Journal of Bone and Mineral Research, vol. 37, no. 12, 2022, pp. 2435–2442, doi:10.1002/jbmr.4672.
Ensrud, K. E., et al. "Association of Disease Definition, Comorbidity Burden, and Prognosis with Hip Fracture Probability Among Late-Life Women." JAMA Internal Medicine, 17 June 2019, doi:10.1001/jamainternmed.2019.1621.
Geusens, P. "Bisphosphonates for Postmenopausal Osteoporosis: Determining Duration of Treatment." Current Osteoporosis Reports, vol. 7, no. 1, 2009, pp. 12–17, doi:10.1007/s11914-009-0003-1.
Gilsenan, A., et al. "Long-Term Cancer Surveillance: Results from the Forteo Patient Registry Surveillance Study." Osteoporosis International, 5 Nov. 2020, doi:10.1007/s00198-020-05738-3.
Adler, R. A., et al. "Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research." Journal of Bone and Mineral Research, vol. 31, no. 1, 2016, pp. 16–35, doi:10.1002/jbmr.2708.
Anastasilakis, A. D., et al. "Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases." Journal of Bone and Mineral Research, vol. 32, no. 6, 2017, pp. 1291-1296, doi:10.1002/jbmr.3110.
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B. (2020). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 26(Suppl 1), 1–46. https://doi.org/10.4158/GL-2020-0524SUPPL
Chou, Sharon, Anjali Grover, and Meryl S. LeBoff. "New Osteoporotic/Vertebral Compression Fractures." National Center for Biotechnology Information, 19 Sept. 2018, https://www.ncbi.nlm.nih.gov/books/NBK279035.
van den Bergh, J. P., Geusens, P., Appelman-Dijkstra, N. M., van den Broek, H. J. G., Elders, P. J. M., de Klerk, G., van Oostwaard, M., Willems, H. C., Zillikens, M. C., & Lems, W. F. (2024). The Dutch multidisciplinary guideline on osteoporosis and fracture prevention, taking a local guideline to the international arena. Archives of osteoporosis, 19(1), 23. https://doi.org/10.1007/s11657-024-01378-3
Kendler, D. L., Bauer, D. C., Davison, K. S., Dian, L., Hanley, D. A., Harris, S. T., McClung, M. R., Miller, P. D., Schousboe, J. T., Yuen, C. K., & Lewiecki, E. M. (2016). Vertebral Fractures: Clinical Importance and Management. The American journal of medicine, 129(2). https://doi.org/10.1016/j.amjmed.2015.09.020
Lentle B, Koromani F, Brown JP, Oei L, Ward L, Goltzman D, et al. (2019). The radiology of osteoporotic vertebral fractures revisited. J Bone Miner Res 34(3):409–418. https://doi.org/10.1002/jbmr.3669
Cooper A (2006). Compliance with treatment for osteoporosis. Lancet 368(9548):1648. https://doi.org/10.1016/S0140-6736(06)69691-8
Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC, et al. (2021). Vertebral fracture: epidemiology, impact, and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int 32(3):399–411. https://doi.org/10.1007/s00198-020-05804-3
Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al. (2019). Efficacy of pharmacological therapies for preventing fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104(5):1623–1630. https://doi.org/10.1210/jc.2019-00192
Zeng LF, Pan BQ, Liang GH, Luo MH, Cao Y, Guo D, et al. (2019). Does routine anti-osteoporosis medication lower the risk of fractures in male subjects? An updated systematic review with meta-analysis of clinical trials. Front Pharmacol 10:882. https://doi.org/10.3389/fphar.2019.00882
Cosman F, Cauley JA, Eastell R, Boonen S, Palermo L, Reid IR, et al. (2014). Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: When is it reasonable to discontinue treatment? J Clin Endocrinol Metab 99(12):4546–4554. https://doi.org/10.1210/jc.2014-1971
Lems WF, Dreinhofer KE, Bischoff-Ferrari H, Blauth M, Czerwinski E, da Silva J, et al. (2017). EULAR/EFORT recommendations for the management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis 76(5):802–810. https://doi.org/10.1136/annrheumdis-2016-210289
Javaid, M.K., Sami, A., Lems, W. et al. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int 31, 1193–1204 (2020). https://doi.org/10.1007/s00198-020-05377-1
John A Eisman, Earl R Bogoch, Rick Dell, J Timothy Harrington, Ross E McKinney, Alastair McLellan, Paul J Mitchell, Stuart Silverman, Rick Singleton, Ethel Siris, for the ASBMR Task Force on Secondary Fracture Prevention, Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention, Journal of Bone and Mineral Research, Volume 27, Issue 10, 1 October 2012, Pages 2039–2046, https://doi.org/10.1002/jbmr.1698
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.